Robin Levis

Robin Levis has worked at the US Food and Drug Administration since 1995. She is currently the Deputy Director of the Division of Viral Products in the Office of Vaccines Research and Review at CBER/FDA; a position she has held since 2006. As Deputy Director, Dr. Levis has review oversight for all regulatory activity in the Division. In addition, she works on global policy efforts for regulatory convergence and on the reduction of animal use in product development and testing. Prior to this position, she served as the Regulatory Coordinator for the Division of Viral Products (2002-2006) and served as a Senior Staff Fellow in the Laboratory of Vector Borne Viral Diseases (1995-2002). Her initial research work at the FDA related to dengue virus replication. She then transitioned to being the lead CMC reviewer for licensed rabies virus vaccine products and rabies vaccine and related products under development. In addition to her work on rabies, Dr. Levis served as the primary CMC reviewer for the Human Papillomavirus (HPV) vaccines to prevent cervical and related cancers. Dr. Levis continues to be involved in the review and regulation of all viral vaccines.